South Korean software provider Hyundai Mobis selected Israel's Cognata, a provider of simulation software and training data for driver-assistance systems and autonomous vehicles, to test its offerings.
Cognata noted that large-scale simulation provides the only environment where autonomous vehicle technology and advanced driver-assistance systems (ADAS) can be safely tested and validated.
The deal brings Cognata's technology to one of South Korea's largest automotive groups during an incredible momentum and growth in autonomous driving and ADAS in South Korea.
Lee Chang-ik, who manages autonomous vehicle simulation in Hyundai Mobis, said Cognata would accelerate their time-to-market offerings.
According to NH Investment & Securities analyst Cho Soo-hong, Hyundai Mobis should see mid to long-term earnings growth as a key automotive electronics provider for Hyundai Motor Group, set to introduce its E-GMP EV-dedicated platform in 2021.


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Instagram Outage Disrupts Thousands of U.S. Users
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



